These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31520536)

  • 1. Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom.
    Chen SC; Dastamani A; Pintus D; Yau D; Aftab S; Bath L; Swinburne C; Hunter L; Giardini A; Christov G; Senniappan S; Banerjee I; Shaikh MG; Shah P
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):770-775. PubMed ID: 31520536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical hypoglycaemia associated with diazoxide therapy for hyperinsulinaemic hypoglycaemia.
    Ponmani C; Gannon H; Hussain K; Senniappan S
    Horm Res Paediatr; 2013; 80(2):129-33. PubMed ID: 23886961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review.
    Timlin MR; Black AB; Delaney HM; Matos RI; Percival CS
    Pediatr Cardiol; 2017 Aug; 38(6):1247-1250. PubMed ID: 28642988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Hypertension Following Increased Dosing of Diazoxide in an Infant.
    Ohnishi Y; Okada S; Yasudo H; Kimura S; Suzuki Y; Hasegawa S
    Int Heart J; 2020 Sep; 61(5):1084-1087. PubMed ID: 32921661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide.
    Herrera A; Vajravelu ME; Givler S; Mitteer L; Avitabile CM; Lord K; De León DD
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4365-4372. PubMed ID: 30247666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial ABCC8 gene deletion mutations causing diazoxide-unresponsive hyperinsulinaemic hypoglycaemia.
    Flanagan S; Damhuis A; Banerjee I; Rokicki D; Jefferies C; Kapoor R; Hussain K; Ellard S
    Pediatr Diabetes; 2012 May; 13(3):285-9. PubMed ID: 21978130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular characterisation of hyperinsulinaemic hypoglycaemia in infants born small-for-gestational age.
    Arya VB; Flanagan SE; Kumaran A; Shield JP; Ellard S; Hussain K; Kapoor RR
    Arch Dis Child Fetal Neonatal Ed; 2013 Jul; 98(4):F356-8. PubMed ID: 23362136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia.
    Banerjee I; Salomon-Estebanez M; Shah P; Nicholson J; Cosgrove KE; Dunne MJ
    Diabet Med; 2019 Jan; 36(1):9-21. PubMed ID: 30246418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype and phenotype correlations in Iranian patients with hyperinsulinaemic hypoglycaemia.
    Senniappan S; Sadeghizadeh A; Flanagan SE; Ellard S; Hashemipour M; Hosseinzadeh M; Salehi M; Hussain K
    BMC Res Notes; 2015 Aug; 8():350. PubMed ID: 26268944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation and treatment response to diazoxide in two siblings with congenital hyperinsulinism as a result of a novel compound heterozygous ABCC8 missense mutation.
    Galcheva S; Iotova V; Ellard S; Flanagan SE; Halvadzhiyan I; Petrova C; Hussain K
    J Pediatr Endocrinol Metab; 2017 Apr; 30(4):471-474. PubMed ID: 28328534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening.
    Maiorana A; Barbetti F; Boiani A; Rufini V; Pizzoferro M; Francalanci P; Faletra F; Nichols CG; Grimaldi C; de Ville de Goyet J; Rahier J; Henquin JC; Dionisi-Vici C
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):679-88. PubMed ID: 24383515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When is it best to discontinue diazoxide in children with persistent hyperinsulinaemic hypoglycaemia and negative genetics for K
    Güemes M; Kostopoulou E; AlYahyaei M; Gilbert C; Shah P
    Clin Endocrinol (Oxf); 2022 Feb; 96(2):107-113. PubMed ID: 34370339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of low-dose diazoxide in small-for-gestational-age infants with hyperinsulinaemic hypoglycaemia.
    Chandran S; R PR; Mei Chien C; Saffari SE; Rajadurai VS; Yap F
    Arch Dis Child Fetal Neonatal Ed; 2022 Jul; 107(4):359-363. PubMed ID: 34544689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trial of diazoxide for small for gestational age neonates with hyperinsulinaemic hypoglycaemia provided early hypoglycaemic control without adverse effects.
    Balachandran B; Mukhopadhyay K; Sachdeva N; Walia R; Attri SV
    Acta Paediatr; 2018 Jun; 107(6):990-995. PubMed ID: 29385640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations.
    Flanagan SE; Kapoor RR; Mali G; Cody D; Murphy N; Schwahn B; Siahanidou T; Banerjee I; Akcay T; Rubio-Cabezas O; Shield JP; Hussain K; Ellard S
    Eur J Endocrinol; 2010 May; 162(5):987-92. PubMed ID: 20164212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy.
    Yildizdas D; Erdem S; Küçükosmanoglu O; Yilmaz M; Yüksel B
    Adv Ther; 2008 May; 25(5):515-9. PubMed ID: 18512033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus therapy in a patient with severe hyperinsulinaemic hypoglycaemia due to a compound heterozygous ABCC8 gene mutation.
    Shah P; Arya VB; Flanagan SE; Morgan K; Ellard S; Senniappan S; Hussain K
    J Pediatr Endocrinol Metab; 2015 May; 28(5-6):695-9. PubMed ID: 25518065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving course of HNF4A hyperinsulinaemic hypoglycaemia--a case series.
    McGlacken-Byrne SM; Hawkes CP; Flanagan SE; Ellard S; McDonnell CM; Murphy NP
    Diabet Med; 2014 Jan; 31(1):e1-5. PubMed ID: 23796040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndromic Forms of Hyperinsulinaemic Hypoglycaemia-A 15-year follow-up Study.
    Kostopoulou E; Dastamani A; Güemes M; Clement E; Caiulo S; Shanmugananda P; Dattani M; Gilbert C; Hurst JA; Shah P
    Clin Endocrinol (Oxf); 2021 Mar; 94(3):399-412. PubMed ID: 33345357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant.
    Durmaz E; Flanagan SE; Parlak M; Ellard S; Akcurin S; Bircan I
    J Clin Res Pediatr Endocrinol; 2014; 6(2):119-21. PubMed ID: 24932607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.